{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": null, "headline": {"main": "Daily Activity Tied to Lower Alzheimer's Risk", "kicker": "well", "print_headline": "Vital Signs: Regimens: Physical Activity and Alzheimer\u2019s Risk"}, "abstract": "Higher levels of daily physical activity in the elderly were associated with a decreased risk of Alzheimer's disease in a new study.", "print_page": null, "word_count": "232", "_id": "4fd3a4368eb7c8105d8ee92c", "snippet": "Higher levels of daily physical activity in the elderly were associated with a decreased risk of Alzheimer's disease in a new study.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2012/04/27/daily-activity-tied-to-lower-alzheimers-risk/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Alzheimer's Disease", "name": "subject", "rank": "1"}, {"value": "Elderly", "name": "subject", "rank": "2"}, {"value": "Exercise", "name": "subject", "rank": "3"}, {"value": "Medicine and Health", "name": "subject", "rank": "4"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Nicholas", "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "blogpost", "pub_date": "2012-04-27T08:16:33Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "David Brennan is leaving as the big British pharmaceutical company struggles with generic competition and lower revenue and profits.", "headline": {"main": "AstraZeneca C.E.O. to Step Down", "print_headline": "As AstraZeneca Profit Falls, Its Chief Is Stepping Down"}, "abstract": "AstraZeneca chief executive David Brennan is stepping down as the company struggles with competition from makers of generic drugs and the failure of several development projects; chief financial officer Simon Lowth will become interim chief while the board conducts a search for a successor; company reports that its revenue for the first quarter fell 11 percent to $7.35 billion, and earnings per share plunged 38 percent.", "print_page": "3", "word_count": "868", "_id": "515b5e27fdc59278db008f4c", "snippet": "David Brennan is leaving as the big British pharmaceutical company struggles with generic competition and lower revenue and profits.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/04/27/business/astrazeneca-ceo-to-step-down.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "AstraZeneca PLC", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Suspensions, Dismissals and Resignations", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Brennan, David", "is_major": "N", "rank": "5", "name": "persons"}, {"value": "Lowth, Simon", "is_major": "N", "rank": "6", "name": "persons"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2012-04-27T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": null, "headline": {"main": "Time to Revisit Food Deserts", "kicker": "Fixes"}, "abstract": "Research on obesity and food availability in poor areas suggests that access must be considered alongside factors like price, taste and education, too.", "print_page": null, "word_count": "1942", "_id": "54f216197988107c2577c803", "snippet": "Research on obesity and food availability in poor areas suggests that access must be considered alongside factors like price, taste and education, too.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://opinionator.blogs.nytimes.com/2012/04/25/time-to-revisit-food-deserts/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Diet and Nutrition", "name": "subject", "rank": "1"}, {"value": "Food", "name": "subject", "rank": "2"}, {"value": "Obesity", "name": "subject", "rank": "3"}, {"value": "Research", "name": "subject", "rank": "4"}, {"value": "Street Vendors", "name": "subject", "rank": "5"}, {"value": "Supermarkets and Grocery Stores", "name": "subject", "rank": "6"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "David", "lastname": "BORNSTEIN"}], "original": "By DAVID BORNSTEIN"}, "document_type": "blogpost", "pub_date": "2012-04-25T07:00:29Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "A study in Las Vegas has found that boxers\u2019 brains may show physical changes in areas that deal with functions like memory and alertness before they exhibit any cognitive declines.", "headline": {"seo": "Study Shows Changes in Fighters&#8217; Brains Before Symptoms", "main": "Study of Fighters Shows Brain Changes Are Seen Before Symptoms", "print_headline": "Study of Fighters Shows Brain Changes Are Seen Before Symptoms"}, "abstract": "Study at the Cleveland Clinic in Las Vegas finds that boxers\u2019 brains may show physical changes in areas that deal with functions like memory and alertness before they exhibit any cognitive declines; doctors who study athletes' brain injuries say research has focused too narrowly on concussions and hard blows to the head rather than more constant lesser blows.", "print_page": "15", "word_count": "800", "_id": "515b5e83fdc59278db008fba", "snippet": "A study in Las Vegas has found that boxers\u2019 brains may show physical changes in areas that deal with functions like memory and alertness before they exhibit any cognitive declines.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/04/25/health/research/study-shows-changes-in-fighters-brains-before-symptoms.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2012/04/25/us/BOXING/BOXING-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2012/04/25/us/BOXING/BOXING-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Research", "keywords": [{"value": "Boxing", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Brain", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Magnetic Resonance Imagers", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Memory", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Cleveland Clinic", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Las Vegas (Nev)", "is_major": "N", "rank": "8", "name": "glocations"}, {"value": "Ohio", "is_major": "N", "rank": "9", "name": "glocations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Timothy", "lastname": "PRATT"}], "original": "By TIMOTHY PRATT"}, "document_type": "article", "pub_date": "2012-04-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine", "lead_paragraph": "For a small group of researchers and their patients facing death, psychedelic drugs aren\u2019t a hippie palliative. They\u2019re a new way to approach the most dire time of life.", "headline": {"main": "How Psychedelic Drugs Can Help Patients Face Death", "print_headline": "A Kaleidoscope at the End of the Tunnel"}, "abstract": "Lauren Slater article on researchers across the country who are investigating the healing power of psychedelic drugs, like LSD and psilocybin, for fear and anxiety in terminal patients.", "print_page": "56", "word_count": "3957", "_id": "515b60b5fdc59278db009277", "snippet": "For a small group of researchers and their patients facing death, psychedelic drugs aren\u2019t a hippie palliative. They\u2019re a new way to approach the most dire time of life.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/04/22/magazine/how-psychedelic-drugs-can-help-patients-face-death.html", "multimedia": [{"subtype": "wide", "url": "images/2012/04/22/magazine/22psychedelics/22psychedelics-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2012/04/22/magazine/22psychedelics/22psychedelics-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2012/04/22/magazine/22psychedelics/22psychedelics-articleLarge.jpg", "height": 701, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2012/04/22/magazine/22psychedelics/22psychedelics-articleLarge.jpg", "xlargeheight": "701"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2012/04/22/magazine/22psychedelics/22psychedelics-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2012/04/22/magazine/22psychedelics/22psychedelics-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Grob, Charles", "is_major": "N", "rank": "1", "name": "persons"}, {"value": "Death and Dying", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Anxiety and Stress", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Research", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "LSD (Lysergic Acid Diethylamide)", "is_major": "Y", "rank": "6", "name": "subject"}, {"value": "Fear (Emotion)", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Psychiatry and Psychiatrists", "is_major": "N", "rank": "8", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "9", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Lauren", "lastname": "SLATER"}], "original": "By LAUREN SLATER"}, "document_type": "article", "pub_date": "2012-04-22T00:00:00Z", "section_name": "Magazine"}], "meta": {"hits": 5, "offset": 0, "time": 32}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}